Tag: c.diff

FDA Approves First Pill Containing Human Feces

Patients needing a fecal microbiota transplant for recurrent Clostridioides difficile (C. diff) infections now have the option of getting stool in pill form. The U.S. Food and Drug Administration (FDA) recently approved Vowst, the first oral biologic drug for fecal microbiota that was shown in clinical trials to be as effective as fecal microbiota transplants given rectally. Biologic…


Decoding Dysbiosis: Are Your Gut Microbes Out of Whack?

In this series, we’ll share how the latest developments in this medical frontier are transforming our approaches to illness and offering new strategies to heal and prevent disease. Previously: Scientists are examining thousands of people’s stools in an effort to infer a “normal” gut microbiome. This would create a standard that should help clinicians and…